I-serous choroidopathy esembindini

I-serous choroidopathy esembindini sisifo esidala ukuba ulwelo lwakhiwe phantsi kweretina. Le yinxalenye yangasemva yamehlo angaphakathi athumela ulwazi lokubona kwingqondo. Oku kulwelo kuyavuza kumaleko wenqanawa wegazi phantsi kweretina. Olu luhlu lubizwa ngokuba yi-choroid.

Unobangela wale meko akaziwa.

Amadoda achaphazeleka rhoqo kunabafazi, kwaye imeko ixhaphake kakhulu kwiminyaka eyi-45. Nangona kunjalo, nabani na unokuchaphazeleka.

Uxinzelelo lubonakala ngathi luyingozi. Izifundo zakuqala zafumanisa ukuba abantu abanolunya, "uhlobo A" ubuntu abaphantsi koxinzelelo oluninzi banokubakho ngakumbi ekuphuhliseni i-serous choroidopathy.

Imeko inokwenzeka kwakhona njengengxaki yokusetyenziswa kweziyobisi ze-steroid.

Iimpawu zingabandakanya:

• Fiphaza kwaye ungaboni kakuhle kwindawo engaboniyo
• Ukuphambuka kwemigca ethe tye ngelihlo lichaphazelekayo
• Izinto ezibonakala zincinci okanye zikude kude nelihlo lichaphazelekayo

Umboneleli wakho wokhathalelo lwempilo uhlala exhaphaza i-serous choroidopathy engaphakathi ngokunyusa iliso kunye nokwenza uvavanyo lwamehlo. I-fluorescein angiography iqinisekisa isifo.

Le meko inokuphinda ifunyanwe kuvavanyo olungafunekiyo olubizwa ngokuba yi-ocular coherence tomography (OCT).

Uninzi lweziganeko luyacaca ngaphandle konyango kwinyanga e-1 okanye ezi-2. Unyango lwe-Laser okanye unyango lwe-photodynamic ukutywina ukuvuza kunokunceda ukubuyisela umbono kubantu abanokuvuza okunzulu kunye nelahleko yombono, okanye kwabo banesifo ixesha elide.

Abantu abasebenzisa iziyobisi ze-steroid (umzekelo, ukunyanga izifo ezizimeleyo) kufuneka bayeke ukusebenzisa la mayeza, ukuba kunokwenzeka. SUKUYEKE ukuthatha la mayeza ungakhange uqale uthethe nomboneleli wakho.

Unyango ngamachaphaza angenayo i-steroidal anti-inflammatory (NSAID) anokunceda.

Uninzi lwabantu lufumana umbono olungileyo ngaphandle konyango. Nangona kunjalo, umbono uhlala ungalunganga njengoko wawunjalo ngaphambi kokuba imeko yenzeke.

Esi sifo sibuyela kwisiqingatha sabantu bonke. Nokuba isifo siyabuya, sinembonakalo elungileyo. Ngokuqhelekileyo, abantu bahlakulela amanxeba angapheliyo awonakalisa umbono wabo ophakathi.

Inani elincinci labantu liya kuba neengxaki zonyango lwe-laser ezonakalisa umbono wabo ophakathi. Yiyo loo nto uninzi lwabantu luya kuvunyelwa ukuba luphile ngaphandle konyango, ukuba kunokwenzeka.

Biza umboneleli wakho ukuba umbono wakho uya usiba mbi.

Akukho sithintelo saziwayo. Nangona kukho ubudlelwane obucacileyo noxinzelelo, abukho ubungqina bokuba ukunciphisa uxinzelelo kunokunceda ukuthintela okanye ukunyanga i-serous choroidopathy.

I-serous retinopathy esembindini

• Iretina

IBahadorani S, iMaclean K, iWannamaker K, et al. Unyango lwe-serous chorioretinopathy esembindini kunye nee-NSAID ezingundaba-mlonyeni. Ikliniki yeOphthalmol. 2019; 13: 1543-1548. IINKCUKACHA: 31616132 pubmed.ncbi.nlm.nih.gov/31616132/.

I-Kalevar A, Agarwal A.I-serous chorioretinopathy esembindini. Ku: Yanoff M, Duker JS, ii-eds. Ophthalmology. Umhla we-5. IPhiladelphia, PA: Elsevier; 2019: isahl 6.31.

I-Lam D, i-Das S, i-Liu S, i-Lee V, i-Lu L. ye-chorioretinopathy esembindini. Ku: Schachat AP, Sadda SVR, Hinton DR, Wilkinson CP, Wiedemann P, ii-eds. URetina kaRyan. Umhla wesi-6. IPhiladelphia, PA: Elsevier; I-2018: isahluko 75.

UTamhankar MA. Ukuphulukana nokubonakalayo: ukuphazamiseka kwendlela yokubuyela emva yomdla we-neuro-ophthalmic. Ku: Liu GT, Volpe NJ, Galetta SL, ii-eds. Liu, Volpe, kunye neGaletta's Neuro-Ophthalmology. Ngomhla wesi-3. IPhiladelphia, PA: Elsevier; I-2019: isahluko 4.